Want to see FR:EXENS full AI Analyst Report?
Top Page
Exosens
(EXENS)
Select Model
Select Model
Rating:64Neutral
Price Target:
€68.00
▲(15.84% Upside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by improving financial performance (growth and profitability turnaround with deleveraging) and supportive technical trends (price above key moving averages with constructive momentum). These positives are meaningfully offset by valuation risk from a very high P/E and a low dividend yield, alongside concerns about 2025 gross-margin compression and weaker free-cash-flow conversion versus 2024.
Positive Factors
Consistent revenue growth
Sustained top-line growth through 2025 signals durable product demand and successful penetration in defense, industrial and scientific markets. Multi-year revenue expansion improves scale economics, supports ongoing R&D and qualification cycles, and increases visibility into future order flows.
Negative Factors
Sharp gross-margin compression
A dramatic drop in gross margin suggests structural mix shifts, pricing pressure or step-up in input costs that materially erode core profitability. Such compression risks undermining operating leverage, reduces funds available for reinvestment, and makes earnings more sensitive to competitive or supply-side shocks.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained top-line growth through 2025 signals durable product demand and successful penetration in defense, industrial and scientific markets. Multi-year revenue expansion improves scale economics, supports ongoing R&D and qualification cycles, and increases visibility into future order flows.
Read all positive factors
Exosens (EXENS) vs. iShares MSCI France ETF (EWQ)
Market Cap
€2.81B
Dividend Yield0.54%
Average Volume (3M)78.40K
Price to Earnings (P/E)93.6
Beta (1Y)0.74
Revenue Growth15.06%
EPS Growth-4.54%
CountryFR
Employees2,000
SectorIndustrials
Sector Strength72
IndustryAerospace & Defense
Share Statistics
EPS (TTM)0.59
Shares Outstanding50,936,750
10 Day Avg. Volume60,876
30 Day Avg. Volume78,401
Financial Highlights & Ratios
PEG Ratio1.44
Price to Book (P/B)5.54
Price to Sales (P/S)5.27
P/FCF Ratio50.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€73.00Price Target Upside24.36% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.78
Revenue Forecast (FY)€538.49M
Exosens Business Overview & Revenue Model
Company Description
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe...
How the Company Makes Money
Exosens makes money primarily by selling specialized photonics hardware to OEMs and institutional customers across defense/security and industrial/scientific markets. Key revenue streams typically include: (1) Product sales of photodetectors and i...
Exosens Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
66
Positive
Cash Flow
63
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 496.79M | 468.20M | 394.10M | 318.80M | 200.75M | 166.17M |
| Gross Profit | 86.56M | 102.20M | 225.60M | 176.81M | 113.95M | 100.03M |
| EBITDA | 162.19M | 142.10M | 115.20M | 83.91M | 51.25M | -101.18M |
| Net Income | 57.59M | 42.70M | 30.70M | 17.14M | 11.21M | -148.97M |
Balance Sheet | ||||||
| Total Assets | 895.00M | 878.90M | 817.00M | 656.41M | 529.25M | 460.52M |
| Cash, Cash Equivalents and Short-Term Investments | 105.20M | 101.90M | 150.20M | 15.53M | 29.00M | 15.93M |
| Total Debt | 269.50M | 280.00M | 261.28M | 311.77M | 255.28M | 208.11M |
| Total Liabilities | 444.20M | 433.30M | 404.40M | 452.35M | 346.20M | 288.41M |
| Stockholders Equity | 450.90M | 445.70M | 412.60M | 204.06M | 183.05M | 172.11M |
Cash Flow | ||||||
| Free Cash Flow | 56.51M | 48.50M | 96.20M | 19.53M | 25.69M | 23.07M |
| Operating Cash Flow | 118.06M | 98.60M | 96.20M | 50.46M | 47.48M | 42.66M |
| Investing Cash Flow | -103.20M | -121.20M | -72.70M | -99.64M | -55.48M | -21.26M |
| Financing Cash Flow | -27.98M | -16.40M | 76.30M | 35.49M | 20.26M | -36.83M |
Exosens Technical Analysis
Negative
58.70
Price Trends
59.74
Negative
60.69
Negative
58.18
Negative
Market Momentum
-1.34
Positive
35.14
Neutral
4.84
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EXENS, the sentiment is Negative. The current price of 58.7 is below the 20-day moving average (MA) of 60.68, below the 50-day MA of 59.74, and above the 200-day MA of 58.18, indicating a bearish trend. The MACD of -1.34 indicates Positive momentum. The RSI at 35.14 is Neutral, neither overbought nor oversold. The STOCH value of 4.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:EXENS.
Exosens Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | €2.81B | 93.56 | ― | 0.54% | 15.06% | -4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | €39.56M | 36.45 | 5.66% | 1.30% | 10.87% | 46.41% | |
53 Neutral | €91.77M | -2.32 | -39.17% | 3.35% | -29.90% | -17.13% | |
38 Underperform | €789.67M | 174.27 | 0.45% | ― | -3.09% | -86.76% |
* Industrials Sector Average
FR:EXENS
Exosens
55.20
17.97
48.28%
FR:XFAB
X-Fab Silicon Foundries SE
6.05
-0.69
-10.18%
FR:MEMS
MEMSCAP SA
5.14
1.43
38.66%
FR:LACR
Lacroix Group SA
19.60
11.82
151.93%
FR:ALARF
Adeunis RF SA
0.84
0.30
55.56%
Exosens Corporate Events
Exosens Files 2026 Half-Year Financial Report With AMF
Jul 28, 2026
Exosens, the France-based high-tech group focused on mission- and performance-critical electro-optical amplification, detection and imaging technologies, operates 13 production and RD sites across Europe and North America and employs more than 2,0...
Exosens to Triple Thermal Camera Output as Drone Defense Demand Surges
Jul 28, 2026
Exosens, a specialist in mission-critical amplification, detection and imaging technologies, is expanding its role in the defense and autonomous systems market with a focus on compact thermal cameras and cooled infrared solutions. The company targ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.